CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Inhalerx Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Inhalerx Ltd
Level 5, 126 Phillip Street
Phone: +61 383955446p:+61 383955446 SYDNEY, NSW  2000  Australia Ticker: LSHLSH
Business Summary
Inhalerx Limited is an Australia-based healthcare company. The Company is focused on developing medicinal drug-device products to address unmet medical needs in the pain management and mental health sectors. The Company partners with educators in their technical and therapeutic fields, to provide inhalation therapies that deliver added value for patients, doctors, business partners, governments, and stakeholders alike. Its Medihale Inhaler is a sealed pod inhaler designed specifically for use with inhaled formulations. It utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material. The sealed tamper-proof Medihale Pods provide patients with additional security. The Medihale Protective Charging Case automatically recharges the Medihale Inhaler when the inhaler is returned to its case. The Medihale Protective Charging Case even has a dedicated storage space to carry an extra Medihale c-liquid Pod.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board SeanWilliams 7/26/2021 7/26/2021
Chief Executive Officer DarrylDavies 9/27/2022 7/20/2021
Chief Scientific Officer RobJenny 9/27/2022 9/27/2022
Company Secretary, Director JamesBarrie 3/1/2024 8/3/2023
Non-Executive Director AndrewSaich 7/20/2021 7/20/2021

Business Names
Business Name
IRX
LSH

General Information
Outstanding Shares: 189,766,957 (As of 6/30/2024)
Shareholders: 575
Stock Exchange: ASX


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024